Sevikar.eu - Sevikar 20 mg/5 mg Film-Coated Tablets - medicines

Provided by Alexa ranking, sevikar.eu has ranked N/A in N/A and 8,391,898 on the world. sevikar.eu reaches roughly 367 users per day and delivers about 11,008 users each month. The domain sevikar.eu uses a Commercial suffix and it's server(s) are located in N/A with the IP number 194.97.156.207 and it is a .eu domain.

WEBPrint patient leaflet in large text. Expand All. Sevikar 20 mg/5 mg, 40 mg/5 mg, 40 mg/10 mg Film-Coated Tablets. This leaflet was last revised in July 2022. Other sources of information. Detailed information on this medicine is available on the web site of: UK/MHRA. sevikar-pil-uk-v16-220704.

List of domain same IP 194.97.156.207

Search Results related to sevikar.eu on Search Engine

Sevikar 20 mg/5 mg Film-Coated Tablets - medicines
medicines.org.uk

https://www.medicines.org.uk/emc/product/6527/pil

WEBPrint patient leaflet in large text. Expand All. Sevikar 20 mg/5 mg, 40 mg/5 mg, 40 mg/10 mg Film-Coated Tablets. This leaflet was last revised in July 2022. Other sources of information. Detailed information on this medicine is available on the web site of: UK/MHRA. sevikar-pil-uk-v16-220704.

DA: 92 PA: 50 MOZ Rank: 22

Sevikar 20 mg/5 mg Film-Coated Tablets - Summary of Product …
medicines.org.uk

https://www.medicines.org.uk/emc/product/6527/smpc

WEBSevikar is a combination of an angiotensin II receptor antagonist, olmesartan medoxomil, and a calcium channel blocker, amlodipine besilate. The combination of these active ingredients has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

DA: 1 PA: 37 MOZ Rank: 98

Sevikar: Uses, Dosage, Side Effects, FAQ - MedicinesFAQ
medicinesfaq.com

https://www.medicinesfaq.com/brand/sevikar

WEBSep 19, 2023 · Sevikar Amlodipine is a dihydropyridine calcium channel blocker that inhibits the transmembrane influx of calcium ions into vascular smooth muscle & cardiac muscle. Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance & a reduction in blood pressure.

DA: 39 PA: 75 MOZ Rank: 69

Sevikar - NPS MedicineWise
nps.org.au

https://www.nps.org.au/medicine-finder/sevikar-40-10-tablets

WEBAug 3, 2022 · SEVIKAR contains olmesartan medoxomil, which belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which causes blood vessels to tighten. SEVIKAR blocks the action of angiotensin-II and therefore relaxes your blood vessels.

DA: 48 PA: 95 MOZ Rank: 84

Sevikar HCT - Summary of Product Characteristics (SmPC)
medicines.org.uk

https://www.medicines.org.uk/emc/product/4596/smpc

WEBSevikar HCT is a combination of an angiotensin II receptor antagonist, olmesartan medoxomil, a calcium channel blocker, amlodipine besilate and a thiazide diuretic, hydrochlorothiazide. The combination of these ingredients has an additive antihypertensive effect, reducing blood pressure to a greater degree than each component alone.

DA: 89 PA: 74 MOZ Rank: 20

Sevikar HCT - NPS MedicineWise
nps.org.au

https://www.nps.org.au/medicine-finder/sevikar-hct-40-10-25-tablets

WEBAug 3, 2022 · SEVIKAR HCT is used to treat high blood pressure which is sometimes called hypertension. Everyone has blood pressure. This pressure helps push blood all around your body. Your blood pressure changes at different times of the day, depending on how busy or worried you are.

DA: 14 PA: 84 MOZ Rank: 84

Sevikar 40/5 | healthdirect
healthdirect.gov.au

https://www.healthdirect.gov.au/medicines/brand/amt,29001000168107/sevikar-40-5

WEBWhat it is used for. SEVIKAR is indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination. How to take it. The way to take this medicine is: Oral. This medicine is taken by mouth. Store below 25 degrees Celsius. Shelf lifetime is 36 Months.

DA: 63 PA: 14 MOZ Rank: 85

Efficacy and safety of olmesartan medoxomil‑amlodipine besylate …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10790165/

WEBDec 5, 2023 · Exp Ther Med. 2024 Feb; 27 (2): 51. Published online 2023 Dec 5. doi: 10.3892/etm.2023.12338. PMCID: PMC10790165. Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar ®) in older patients with essential hypertension: Subgroup analysis from the Sevikar study.

DA: 17 PA: 88 MOZ Rank: 38

Sevikar HCT 40/10/25 | healthdirect
healthdirect.gov.au

https://www.healthdirect.gov.au/medicines/brand/amt,18531000168109/sevikar-hct-40-10-25

WEBSEVIKAR HCT is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see DOSAGE AND ADMINISTRATION).

DA: 52 PA: 77 MOZ Rank: 76

How to take SEVIKAR - NPS MedicineWise
nps.org.au

https://www.nps.org.au/assets/medicines/c5271eed-abc3-45a1-a734-a53300ff5214.pdf

WEBWhat SEVIKAR is used for. SEVIKAR is used to treat high blood pressure which is sometimes called hypertension. Everyone has blood pressure. This pressure helps push blood all around your body. Your blood pressure changes at different times of the day, depending on how busy or worried you are.

DA: 7 PA: 90 MOZ Rank: 12

Alexa Rank

GLOBAL RANK

8,391,898

Alexa Reach

0.0000161977

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

367

Monthly Unique Visitors

11,008

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

2,355

Indonesia

1,842

Taiwan

599

United Kingdom

532

Brazil

481

Nigeria

421

Egypt

353

Hong Kong

334

Canada

334

Australia

291

Philippines

208

India

203

Malaysia

199

Spain

165

Germany

161

Mexico

154

France

145

Italy

134

Turkey

123

Iraq

112

Thailand

110

Netherlands

106

Israel

105

Cambodia

Algeria

Ireland

Romania

Jordan

Poland

Ghana

Argentina

South Africa

Belgium

Czechia

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra

Hosting and Whois Zone

IP	194.97.156.207
Domain infomation	% The WHOIS service offered by EURid and the access to the records % in the EURid WHOIS database are provided for information purposes % only. It allows persons to check whether a specific domain name % is still available or not and to obtain information related to % the registration records of existing domain names. % % EURid cannot, under any circumstances, be held liable in case the % stored information would prove to be wrong, incomplete or not % accurate in any sense. % % By submitting a query you agree not to use the information made % available to: % % - allow, enable or otherwise support the transmission of unsolicited, % commercial advertising or other solicitations whether via email or % otherwise; % - target advertising in any possible way; % % - to cause nuisance in any possible way to the registrants by sending % (whether by automated, electronic processes capable of enabling % high volumes or other possible means) messages to them. % % Without prejudice to the above, it is explicitly forbidden to extract, % copy and/or use or re-utilise in any form and by any means % (electronically or not) the whole or a quantitatively or qualitatively % substantial part of the contents of the WHOIS database without prior % and explicit permission by EURid, nor in any attempt hereof, to apply % automated, electronic processes to EURid (or its systems). % % You agree that any reproduction and/or transmission of data for % commercial purposes will always be considered as the extraction of a % substantial part of the content of the WHOIS database. % % By submitting the query you agree to abide by this policy and accept % that EURid can take measures to limit the use of its WHOIS services % in order to protect the privacy of its registrants or the integrity % of the database. % % The EURid WHOIS service on port 43 (textual whois) never % discloses any information concerning the registrant. % Registrant and on-site contact information can be obtained through use of the % webbased WHOIS service available from the EURid website www.eurid.eu % % WHOIS sevikar.eu Domain: sevikar.eu Script: LATIN Registrant: NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. On-site(s): NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. Registrar: Name: MarkMonitor International Limited Website: https://www.markmonitor.com/ Name servers: ns5.markmonitor.com ns2.markmonitor.com ns3.markmonitor.com ns4.markmonitor.com ns1.markmonitor.com ns7.markmonitor.com ns6.markmonitor.com Please visit www.eurid.eu for more info.